No Second Chances, Controlling Risk in Cardiovascular Disease. Baker Heart and Diabetes Institute, 2019.
Catapano AL. Wiklund O. Think again about cholesterol survey. Atherosclerosis Supplements. 2015;20:1-5
Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European Journal of Cardiovascular Prevention & Rehabilitation. 2007;14(2_suppl):E1-E40.
Carrington M, Cao T, Haregu T, Gao L, Moodie M, Yiallourou S, et al. CODE RED: Overturning Australia’s cholesterol complacency. Melbourne, Australia: Baker Heart and Diabetes Institute, 2020.
